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Summary
Objective: To identify metabolic biomarkers that can be evaluated in serum for monitoring the effects of exercise on skeletal development in
mammals.
Design: Sera of foals from three groups (box-stall rest, pasture and training) were serially collected over the first 5 months of life and assayed
for eight biomarkers of cartilage and bone metabolism. Sub-populations from each group were sampled for an additional 6 months of
identical exercise.
Results: When expressed as a percentage of baseline values, lower serum levels of the carboxy-terminal propeptides of type II collagen
(CPII), and higher serum levels of the cross-linked telopeptide fragments of degraded type I collagen (CTx1) were found in the trained foals
compared to the other groups. Significant differences disappeared in those foals sampled during an additional 6 months of identical exercise.
The most significant correlations were between serum biomarkers of bone metabolism, being positive between anabolic markers and
negative between anabolic and catabolic markers. Serum levels of CTx1 and CPII significantly increased with age in all groups throughout
the study.
Conclusions: We have identified two markers of collagen metabolism, CPII and CTx1, as potential serum indicators of the exercise effects
on the developing skeletal system in horses. Forced exercise during the first months postpartum appeared to have a negative effect on
collagen turnover when compared to levels in pastured foals. Routine monitoring of collagen biomarkers in sera of exercising young
mammals may allow for the early detection of abnormalities in skeletal tissue metabolism and for subsequent intervention before permanent
damage occurs.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
All components of articulating joints participate in load
transmission, and failure of the bone, articular cartilage,
muscles, ligaments/tendons or nerves of a joint may lead to
exercise-induced damage. The ability to detect these
changes at an early stage would potentially enhance one’s
ability to modulate exercise programs on an individual
basis, thereby avoiding irreversible damage to joint struc-
tures. One such diagnostic tool, that has been receiving
expanding attention for the early diagnosis and monitoring
of orthopedic diseases in general, is the evaluation of body
fluid levels of byproducts of skeletal tissue metabolism.
In humans, it has generally been shown that the type,
intensity and duration of exercise are critical in determining
its effect on bone metabolism. For example, serum levels of
biomarkers of bone formation, such as bone-specific alka-
line phosphatase and osteocalcin, have been shown to
either increase1–6 or decrease5,7–9 in human athletes,
dependent upon the exercise regimen. Similarly in animals,
the effects of exercise on bone metabolism vary with the
type and duration of exercise. Significantly greater
subchondral bone volume and bone formation have been
identified in the metacarpal bones of treadmill-exercised
compared to hand-walked 2-year-old horses10, despite no
significant differences in serum osteocalcin levels between
the two groups of horses over 6 months11. In other studies,
baseline serum osteocalcin levels dropped during a 6-week
training program12, but significantly increased after 6
months of race training13 in young Standardbred horses. In
a study involving 2-year-old Thoroughbreds, it was shown,
by evaluating the serum levels of three biomarkers of bone
metabolism serially sampled over 12 months, that there
was a general increase in bone turnover with a regimen
including treadmill exercise compared to normal daily walk-
ing14. We have shown more recently that the serum levels
of a panel of biomarkers of both bone and cartilage
metabolism significantly increased with treadmill exercise
Funding: Morris Animal Foundation, Englewood, CO, USA.
*Address correspondence and reprint requests to: Dr R. Clark
Billinghurst, Orthopaedic Research Center, Department of Clinical
Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Tel: 1-970-297-4593; Fax: 1-970-297-4138; E-mail: rbilli@lamar.
colostate.edu
Received 23 January 2003; revision accepted 25 June 2003.
International
Cartilage
Repair
Society
OsteoArthritis and Cartilage (2003) 11, 760–769
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/S1063-4584(03)00152-3
760
in horses and could be used to discriminate exercise-
induced changes from pathology due to surgically induced
osteoarthritis15.
As with all other joint tissues, including the subchondral
bone, it is generally believed that systemic factors includ-
ing age, sex and genetics establish basic properties of
articular cartilage. However, local biomechanical factors,
such as degree of joint loading and deformity, have a
significant effect on the final qualities of articular carti-
lage16. It has been hypothesized that regular joint loading
during youth is important for the development of a well-
organized and strong articular cartilage collagen network,
and that this contributes to the prevention of osteo-
arthritis later in life17,18. The maintenance of normal
articular cartilage composition, structure, and function
depends on repetitive joint use19. Marked decreased
use (disuse) or abuse of normal joints through high
intensity impact loading may be associated with degenera-
tive changes in the articular surface. Moreover, normal
use of abnormal joints, such as malaligned or unstable
joints, may increase the risk of degenerative joint
disease.
To date, few studies have looked at the effect of exercise
specifically on articular cartilage and on body fluid levels of
biomarkers of articular cartilage metabolism. The two main
structural components of the articular cartilage matrix are
type II collagen and aggrecan. Changes suggestive of
microdamage and weakening of the type II collagen net-
work of articular cartilage have been reported in strenu-
ously exercised young racehorses20, whereas moderate
exercise has been shown to have a beneficial effect on
glycosaminoglycan (GAG) content of articular cartilage in
young21 and adult22 horses. It has been reported that the
serum and synovial fluid levels of keratan sulfate, a GAG
found on the individual proteoglycan molecules of aggre-
can, are increased in young horses and ponies as a result
of exercise13,23,24.
The young horses used in the current study were part of
a larger project designed to investigate the effects of
exercise on musculoskeletal development, as well as the
occurrence and severity of the developmental orthopedic
disease, osteochondrosis. Foals were subjected to stall
rest, pasturing or an increasing level of training from 1 week
to 5 months of age, after which time a cohort from each
group was allowed free pasture access for an additional 6
months. For the training group, an exercise regimen was
chosen that was extreme enough to allow for the detection
of a treatment effect in the foals during their first 5 months
of life. It has already been reported that the exercise
regimen used did not appear to have an etiological role in
the osteochondrotic joint lesions identified in these foals25.
However, there were some significant exercise-induced
changes noted in the mineral density of certain appendicu-
lar bones26–28, in tendon29 and subchondral bone compo-
sition30, and in the proteoglycan synthetic capacity31 and
GAG content20 of articular cartilage from various joints of
the foals.
We hypothesized that the effects of the different levels of
exercise on skeletal tissue metabolism in these foals during
the first months of life could be detected at the molecular
level by evaluating the concentrations of a panel of eight
biomarkers of cartilage and bone metabolism in serially
sampled blood. From the results of these assays, it may be
possible to determine which biomarkers could be used to
identify and modulate those exercise regimens that are
harmful to proper skeletal development, before there is
permanent damage.
Methods
ANIMALS
This study involved 43 Dutch Warmblood foals (23
males, 20 females) that were all born in the same year and
housed on the same stud farm in the Netherlands. They
were part of a large project investigating the effect of
exercise on osteochondrosis and musculoskeletal develop-
ment in the foal32. All sires and 11 of the 43 dams
had radiographic evidence of osteochondrosis in the
femoropatellar/femorotibial (stifle) or tibiotarsal (hock)
joints.
EXERCISE REGIMENS
The foals were kept in a paddock with the mares for the
first week after birth and then allotted randomly to three
groups (blocked for sex and sire) until weaning at 5 months
of age. One group (Groupbox) was confined to box stalls of
3×3.5 m (n14). Another group (Grouptraining) was kept in
similar-sized box stalls but also given an increasing number
of gallop sprints for 6 days a week (n14). The number of
sprints was 16 from day 8 to 24, 24 from day 25 to 38, and
then 32 and 16 sprints on alternate days until 5 months of
age. After the sprint training sessions, these foals were
given 0.5 h of free exercise in a 48×15 m enclosure. A third
group (Grouppasture) was kept at pasture 24 h a day (n
15). At 5 months of age, eight foals were randomly removed
from each group for further examinations. The remaining
19 foals were kept together for an additional 6 months
under similar conditions of an open loose box with paddock
access and no training. The Utrecht University Ethical
Committee approved all procedures involving these
horses.
SAMPLES
Blood samples were obtained from the jugular veins of
the 43 foals in the first week after birth and then monthly
until 5 months of age, after which time they were collected
at 7, 9 and 11 months in the remaining 19 foals. All blood
samples were collected at the same time in the morning
(08:00 h) in an attempt to control for the diurnal variation
often noted in humans, especially for biomarkers of bone
resorption, such as with serum CTx1 measured in this
study33. The blood was collected into serum tubes and
centrifuged at 3000 rpm for 10 min within 30 min of collec-
tion. The sera were aliquoted into cryotubes and frozen to
−20°C within 90 min. Upon receipt of the frozen samples
at the Orthopaedic Research Center of Colorado State
University, the aliquots were kept at −80°C until assayed for
biomarker levels.
BIOMARKER ANALYSES
Collagen markers
The individual alpha chains of procollagen molecules are
synthesized with extensions at both the amino- (N-) and
carboxy- (C-) termini called ‘propeptides’. With extracellular
fibril formation, there is proteolytic removal of these propep-
tides from the triple-helical procollagen molecules and
these can be detected in tissues and body fluids as
indicators of collagen synthesis. The serum levels of the
C-propeptide of type I collagen were estimated using a
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commercially available radioimmunoassay (PICP, Dia-
Sorin, Stillwater, MN) that has been validated for equine
use34. In our study, the equine sera were diluted 1:10, and
the intra- and inter-assay coefficient of variation (CV) was
less than 6 and 7%, respectively. Type II collagen synthesis
was estimated using a newly available commercial ELISA
(CPII Assay, IBEX Technologies, Montreal, Canada). This
assay utilizes the same rabbit polyclonal IgG antiserum
employed in a radioimmunoassay for the C-propeptide of
type II collagen that has previously been validated for
equine use35,36. In our study, the equine sera were diluted
1:2, and the intra- and inter-assay CV for CPII levels was
less than 4 and 11%, respectively.
It is believed that the initiating factor in the degradation of
the triple-helical collagen molecule is its cleavage into 3/4-
and 1/4-length fragments by mammalian collagenases
belonging to the matrix metalloproteinase (MMP)
family, specifically MMP-1, MMP-8 and MMP-13. The
collagenase-generated termini of the individual cleaved
alpha chain fragments are ‘neoepitopes’ and antibodies
have been produced to detect these in tissues and fluids.
We estimated the levels of type II collagen degradation in
the foals by using the recently described 234CEQ assay37.
This immunoassay was developed to react specifically with
the collagenase-generated C-termini of the 3/4-length frag-
ments of type II collagen of horses. In our study, the sera
were diluted 1:2, and the intra- and inter-assay CV for
234CEQ was less than 4 and 14%, respectively. An esti-
mation of type I collagen cleavage by collagenases was
made by incorporating the previously described COL2-3/
4Cshort ELISA38,39. As this assay detects 3/4-length frag-
ments of both types I and II collagen38,40, the relative
amount of collagenase-generated fragments of type I col-
lagen was calculated by subtracting the 234CEQ values for
type II collagen cleavage from the COL2-3/4Cshort values
for types I and II collagen cleavage. In our study, the equine
sera were diluted 1:10, and the intra- and inter-assay CV
for the COL2-3/4Cshort assay was less than 11 and 33%,
respectively.
We also evaluated overall type I collagen turnover by
measuring the serum levels of cross-linked degradation
products with a sandwich assay (Serum CrossLaps™ One
Step ELISA, Osteometer A/S, Herlev, Denmark) according
to the manufacturer’s instructions. This assay recognizes
cross-linked and -isomerized C-terminal telopeptide frag-
ments (CTx1) released into the circulation when type I
collagen is degraded by osteoclasts during bone resorp-
tion. This ELISA has been validated by the manufacturer for
use in the horse. In our study, the equine sera were
assayed neat, and the intra- and inter-assay CV for CTx1
was less than 4 and 9%, respectively.
Noncollagenous protein markers
Two molecular markers that are believed to be indicative
of anabolic processes in skeletal tissues are osteocalcin
and the chondroitin sulfate 846 epitope (CS-846). Osteo-
calcin is a small, noncollagenous protein synthesized
mainly by osteoblasts and is believed to be associated with
mineralization of newly formed osteoid. A commercial
ELISA (NovoCalcin®, Metra Biosystems, Mountain View,
CA), that detects equine osteocalcin41, was used to assay
serum levels of osteocalcin, according to the manu-
facturer’s instructions. In our study, the equine sera
were diluted 1:5, and the intra- and inter-assay CV for
osteocalcin was less than 4 and 9%, respectively.
Aggrecan molecules are a main component of the extra-
cellular matrix of articular cartilage and are responsible for
the compressive strength of this tissue. Studies have
suggested that aggrecan synthesis is reflected by the
presence of an epitope called 846, found on some newly
synthesized aggrecan molecules42–45. A newly developed
commercial ELISA for the 846 epitope (CS-846, IBEX
Technologies, Montreal, Canada) was used in our study. It
utilizes the same mouse monoclonal IgM antibody em-
ployed in a radioimmunoassay for this epitope that has
previously been described43. This antibody has been vali-
dated to cross-react with equine aggrecan35,36. In our
study, the equine sera were diluted 1:5, and the intra- and
inter-assay CV for CS-846 was less than 8 and 22%,
respectively. As a general indicator of proteoglycan turn-
over, the serum levels of sulfated glycosaminoglycans
(sGAG) were determined using a previously described
dimethylmethylene blue (DMMB) colorimetric assay46. In
our study, the equine sera were diluted 1:2, and the intra-
and inter-assay CV for sGAG levels was less than 10 and
11%, respectively.
STATISTICAL ANALYSIS
The measurements obtained for the majority of the
biomarkers evaluated in this study (except osteocalcin and
PICP) did not follow a Gaussian distribution as determined
using a Kolmogorov–Smirnov test. Therefore, all biomarker
values were transformed to logarithms (base 10) allowing
the use of statistical tests based on a normal distribution. In
addition to determining the precision of each assay utilizing
equine sera, by calculating the intra- and inter-assay CV%
for each assay (as reported above), linearity was confirmed
by serially diluting samples and comparing the observed
values with the expected values. To compare the effects of
both age, exercise group and the interaction of age and
exercise group on the serum levels of each of the bio-
markers in all foals (n43) over the first 5 months of age, a
repeated measures ANOVA was performed using an
autoregressive correlation structure for the repeated
measures effect of months. This comparison was also
performed for the levels of all biomarkers for those foals
(n19) that were sampled from 0 to 11 months. This was
to determine if the exercise regimens used from 1 week to
5 months of age had any lasting effects on serum bio-
marker levels, after allowing these foals similar exercise
from 5 to 11 months of age. Where significance was
detected (P<0.05), a Least Squares Means procedure was
used involving t tests to detect the significant pair-wise
differences in mean serum levels between the exercise
groups and between months for that biomarker. Due to
significant differences between the groups in the baseline
(week 1) serum values of some biomarkers (Table I), the
percent change from baseline in the serum levels for
each foal at each time point was calculated for each
biomarker. This allowed for the detection of exercise effects
on the baseline levels, determined before the foals were
put into their respective groups. Mean foal weights were not
significantly different between the groups (Table I).
Significant correlations between the serum levels of all
biomarkers were determined by Pearson correlation analy-
sis, using the logarithmically transformed values. All stat-
istical analyses were performed using SAS software,
version 8e (SAS Institute, Cary, NC).
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Results
EXERCISE-RELATED CHANGES IN SERUM BIOMARKER LEVELS
DURING THE FIRST 5 MONTHS OF LIFE
There was a significant exercise-group effect on the
serum levels of the type I collagen degradation biomarker
CTx1 (P0.032) and the type II collagen synthesis biomar-
ker CPII (P0.005). The percent change from baseline in
the serum levels of CTx1 was significantly less in the
Grouppasture compared to both the Grouptraining (P0.028)
and Groupbox foals (P0.019). This suggested that free
pasture exercise resulted in less type I collagen degrada-
tion than either forced strenuous exercise or box-stall rest
in these young horses. After an initial drop from baseline
values at 1 month (Fig. 1), the mean serum levels of CTx1
increased for all exercise groups, such that by 5 months of
age, the groups had reached similar increases from base-
line values (Groupbox184.116.2%, Grouppasture
200.220.1%, and Grouptraining200.338.3%). Moreover,
although there was no significant effect of exercise (P
0.095) on the serum levels of the cleavage fragments of
type I collagen (calculated as COL2-3/4Cshort−234CEQ),
there were significantly higher levels in the Grouptraining
foals compared to Groupbox foals (P0.042). This finding
further suggests that there was increased type I collagen
degradation with the forced exercise in the trained foals
during the first 5 months of life.
There were significantly smaller increases from base-
line for the serum levels of CPII in the Grouptraining foals
compared to both the Grouppasture (P0.0015) and
Groupbox (P0.035) foals, suggesting less type II collagen
synthesis with forced exercise in these foals during the first
5 months of life. After an initial increase at 1 month of age
for all foals (Fig. 2), the CPII levels in the Groupbox foals
stayed essentially the same while the levels in the other
two groups decreased at 2 months of age, and more or less
increased thereafter. As with the CTx1 levels, all groups
reached similar percent increases above baseline values
for CPII at 5 months of age (Groupbox131.211.7%,
Grouppasture139.215.8%, and Grouptraining144.8
11.5%).
None of the other biomarkers evaluated in this study
revealed significant differences between the groups in
terms of their respective percent changes from serum
baseline values. Although the differences were not statisti-
cally significant, the percent change from baseline in the
serum levels of PICP, a marker for type I (bone) collagen
synthesis, was greater for the trained and stall-rested foals,
compared to the pastured foals, at each sampling point
during the 5-month exercise period (Fig. 3). Coupled
with the findings of increased type I collagen degradation
reported above, this suggests increased bone turnover in
both these groups of foals.
THE RESIDUAL EFFECTS OF EXERCISE ON SERUM BIOMARKER
LEVELS (0–11 MONTHS)
The serum levels of each biomarker were analyzed for a
continuation of significant exercise and age effects over the
6 months following the end of the different exercise regi-
mens in those 19 foals sampled until 11 months of age.
Exercise group had no significant effect on the serum levels
of any of the biomarkers evaluated in this study when
considered over the entire 11 months. In other words, while
CTx1 and CPII were significantly related to exercise group
up to 5 months of age, these relationships disappeared in
Table I
Baseline comparisons between the foals classified by exercise group
Group Sex Weight
(kg)
PICP
(ng/mL)
CPII
(ng/mL)
C2Cshort(ng/mL)
234CEQ
(ng/mL)
CTx1
(pM)
OC
(ng/mL)
CS-846
(ng/mL)
sGAG
(µg/mL)
Boxstall 9M/5F 63.1 3263.7 477.4 1026.3 68.6 1146c 108.2 1089.5 65.1
(1.8) (465.3) (52.7) (301.3) (23.8) (140.4) (16.1) (118.2) (10.7)
Pasture 8M/7F 58.1 3385.1 522.4a 906.5b 28.7 857.4c,d 118e 1143.7 57.1
(1.8) (232.5) (35.8) (242.6) (12.7) (104.6) (14.3) (119.8) (5.1)
Training 6M/8F 59.9 3230.9 387.8a 1933.4b 50.4 1512.6d 95.8e 1203.1 49.9
(1.6) (417.1) (26.2) (598.6) (12.6) (390) (15.1) (196.5) (3.5)
Shown are the mean values (±S.E.M.) for the birth weights and baseline levels (1 week of age) of the serum biomarkers in the foals
according to exercise group. Mean serum levels with similar superscripted letters indicate significant differences (P<0.05) between those
groups for that biomarker. See text for definitions (C2Cshort=COL2-3/4Cshort and OC=osteocalcin).
Fig. 1. Exercise and the serum levels of CTx1. Foals were divided
into three different groups at 1 week of age and blood sampled
monthly to 5 months of age. Values are expressed as a percentage
of the baseline (1 week) concentrations and represent the
means±S.E.M. Shown are the comparisons in monthly serum levels
for the box stall-rested (· · ·j· · ·), pastured (—*—) and trained
(- -M- -) foals. Significant differences between pastured and
trained foals are indicated by an asterisk for P<0.05.
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the subsequent 6 months. This suggests that, with subse-
quent paddock exercise, the foals were able to recover
from the previously described effects of the different exer-
cise regimens on collagen metabolism during the first 5
months. This is supported by the fact that significant
interaction between exercise group and age was identified
for CTx1 (P0.0082) for the entire 11 months, indicating
that exercise did not have the same effect on the serum
levels of this biomarker at all ages in these foals.
CORRELATIONS BETWEEN THE SERUM BIOMARKER LEVELS
DURING THE FIRST 11 MONTHS OF LIFE
Significant positive correlations were identified between
some of the anabolic biomarkers, and between some of the
catabolic markers evaluated in this study (Table II). The
serum levels of PICP and osteocalcin, two putative markers
of bone synthesis, had the highest correlation coefficient for
any two biomarkers (r0.5821, P<0.0001). The next two
highest correlation coefficients were between these same
two bone synthesis biomarkers (PICP and osteocalcin) and
CS-846, a putative indicator of aggrecan synthesis (r
0.5204 and r0.4426, respectively; both P<0.0001). The
two biomarkers of type I (bone) collagen degradation, CTx1
and COL2-3/4Cshort, were also positively and significantly
correlated (r0.1508, P0.0073).
The most significant negative correlations were all
between a marker of catabolism and a marker of anabo-
lism. The serum levels of the type I (bone) collagen
degradation marker, CTx1, were significantly and inversely
related to those for bone synthesis markers PICP
(r0.4135, P<0.0001) and osteocalcin (r0.4016,
P<0.0001), as well as the putative aggrecan synthesis
marker CS-846 (r0.4289, P<0.0001). There were also
significant negative correlations between the serum levels
of the marker of type II (cartilage) degradation, 234CEQ,
and the two putative markers of cartilage synthesis,
CPII (r0.1975, P0.0004) and CS-846 (r0.1584,
P0.0044).
THE EFFECT OF AGE ON SERUM BIOMARKER LEVELS DURING THE
FIRST 11 MONTHS OF LIFE
For each of the biomarkers evaluated, except the
collagenase-generated neoepitopes of type I and type II
Fig. 2. Exercise and the serum levels of CPII. Foals were divided
into three different groups at 1 week of age and blood sampled
monthly to 5 months of age. Values are expressed as a percentage
of the baseline (1 week) concentrations and represent the
means±S.E.M. Shown are the comparisons in monthly serum levels
for the box stall-rested (· · ·j· · ·), pastured (—*—) and trained
(- -M- -) foals. Significant differences between pastured and
trained foals are indicated by an asterisk for P<0.05.
Fig. 3. Exercise and the serum levels of PICP. Foals were divided
into three different groups at 1 week of age and blood sampled
monthly to 5 months of age. Values are expressed as a percentage
of the baseline (1 week) concentrations and represent the
means±S.E.M. Shown are the comparisons in monthly serum levels
for the box stall-rested (· · ·j· · ·), pastured (—*—) and trained
(- -M- -) foals. No significant differences were detected between
the different groups of foals.
Table II
Correlations between the serum concentrations of biomarkers of cartilage and bone metabolism (n43)
CS-846 CPII 234CEQ PICP CTx1 C2Cshort Osteocalcin
sGAG 0.0310 0.0375 0.0828 −0.0289 −0.0327 0.0658 −0.0162
CS846 −0.0333 −0.1584 (0.0044) 0.5204 (<0.0001) −0.4289 (<0.0001) 0.1706 (0.0024) 0.4426 (<0.0001)
CPII −0.1975 (0.0004) −0.1362 (0.014) −0.0934 0.0192 0.0434
234CEQ −0.0488 −0.0179 −0.1044 −0.0609
PICP −0.4135 (<0.0001) 0.0495 0.5821 (<0.0001)
CTx1 0.1508 (0.0073) −0.4016 (<0.0001)
C2Cshort −0.0157
Values are the Pearson correlation coefficients (r) for transformed (log10) marker values. Significant P values (<0.05) are shown in
parentheses. See text for definitions (C2Cshort=COL2-3/4Cshort).
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collagens (COL2-3/4Cshort and 234CEQ), there was a
significant age effect for the serum levels during the first 11
months of life (Fig. 4). For all of the markers significantly
affected by age, except CTx1 and CPII, the overall relation-
ship was an inverse one of decreasing serum levels with
increasing age (P<0.0001). Conversely, the serum levels of
CTx1 (P<0.0001) and, less dramatically, CPII (P0.027)
were positively correlated to age in these foals. As would be
expected given the strong correlation between age and
weight (r20.92), these relationships were maintained for
each biomarker and foal weight (not shown). There were no
significant differences between any of the biomarkers
based on foal gender.
Looking at each of these biomarkers, the mean serum
levels of the synthesis biomarkers osteocalcin and CS-846,
after increasing during the first month of life, sharply
decreased with increasing age to 7 months before leveling
off through to 11 months [Fig. 4(A, B)]. The mean serum
levels of PICP also decreased with increasing age, but
there was no initial increase during the first month of life
[Fig. 4(C)]. CPII serum levels gradually increased with age
in foals up to 5 months of age, before they leveled off from
7 to 11 months [Fig. 4(D)]. After an initial drop at 1 month of
age, the serum CTx1 and GAG levels increased with age
from 1 to 5 months in our foals, and this trend continued to
9 months for CTx1 [Fig. 4(E)] but reversed itself for serum
GAG levels [Fig. 4(F)]. As described above, there were no
significant relationships between the mean serum levels of
the collagen cleavage-site neoepitopes and age in these
foals [Fig. 4(G, H)], despite a trend for increasing COL2-3/
4Cshort levels with age.
Discussion
The ability to monitor the molecular activities of skeletal
tissues through the evaluation of body fluid levels of meta-
bolic byproducts or ‘biomarkers’ offers the opportunity
for identifying disturbances indicative of early structural
damage. The goal of this study was to identify which
biomarkers, from a panel of well-characterized indicators of
anabolic and catabolic processes within bone and carti-
lage, could monitor exercise-induced changes in these
tissues in young, developing horses. Of the eight bio-
markers evaluated during the first 5 months of life, only the
changes in the serum levels of a specific C-terminal cross-
linked telopeptide of type I collagen (CTx1) and the
C-terminal propeptide of type II collagen (CPII) were sig-
nificantly different amongst the exercise groups. Trained
foals had significantly higher percent changes from base-
line in serum levels for CTx1 (suggesting increased bone
collagen degradation), and significantly lower changes
from baseline for CPII (reflecting decreased cartilage col-
lagen synthesis), compared to pastured foals. The forced
exercise during the early postpartum months may have had
a negative effect on collagen metabolism relative to free
pasture exercise.
Type I collagen accounts for 90% of the organic matrix of
bone and when degraded, small peptide fragments are
released into the blood. The Serum CrossLaps™ One
Step ELISA used in this study measures the levels of a
cross-linked telopeptide fragment of type I collagen (CTx1)
containing two chains of the amino-acid sequence EKAHD-
-GGR, where the aspartic acid residue (D) is -
isomerized, as indicated. These fragments have high
specificity and sensitivity for monitoring antiresorptive
therapy in horses47 and in humans with metabolic bone
diseases48. There are few reports of their use to assess the
effects of exercise on bone metabolism. Studies involving
young human athletes have shown significantly higher
serum levels of CTx1 with exercise5,49. Increases in serum
levels of ICTP, another cross-linked telopeptide fragment of
type I collagen, have been demonstrated with long distance
running in regularly exercising humans6 and in young,
treadmill-exercised horses12,14.
For the foals in our study, it was previously reported that
exercise, and in particular the sprint training, enhanced
bone mineral density27. The significantly elevated changes
in the serum levels of type I collagen degradation products
in our trained foals support the concept of increased bone
turnover with increased exercise. This is further suggested
by the fact that the changes in the serum levels of the bone
formation marker PICP were higher for the trained than for
the pastured foals at each sampling point during training.
This has also been reported for young horses that were
treadmill-exercised for 1 year when compared with walked
controls14.
The foals confined to box stalls for 5 months also had
significantly higher increases in the serum levels of CTx1
than those at pasture. Higher urinary levels of deoxypyridi-
noline cross-links have been noted in young confined
horses, compared to levels in pastured horses50. These
cross-links predominate in bone collagens and, like CTx1
and ICTP, can monitor bone degradation. Although not
biomechanically the same as box-stall rest, there were
increased serum levels of CTx1 in cosmonauts after only
8 days of space flight51,52. These studies suggest a need
for minimal exercise and joint loading for normal bone
collagen turnover.
The C-propeptide of type II collagen represents a poten-
tial marker of type II collagen synthesis, as its content and
release are directly correlated with collagen synthesis in
normal and osteoarthritic articular cartilages53. The levels
of this propeptide have been measured in body fluids from
humans with various arthritides44,53–56 and significantly
elevated serum levels have been reported in horses
with osteochondral fragmentation35. We recently described
a direct correlation between serum CPII levels and the
severity of osteochondrosis in the same foals used in the
current study57. These findings support those of increased
Fig. 4. Longitudinal changes in serum levels of the biomarkers of bone (A, C, E, G) and cartilage (B, D, F, H) metabolism with age in foals
with varying degrees of osteochondrosis. The synthesis markers shown are osteocalcin (A), CS-846 (B), PICP (C) and CPII (D). The
degradation markers plotted are CTx1 (E), sGAG (F), COL2-3/4Cshort (G) and 234CEQ (H). Values represent the means±S.E.M. (n19).
CS-846=846 epitope of newly synthesized aggrecan; PICP=C-propeptide of type I procollagen; CPII=C-propeptide of type II procollagen;
CTx1=cross-linked telopeptide fragment of type I collagen; sGAG=sulfated glycosaminoglycans; COL2-3/4Cshort=collagenase-generated
cleavage neoepitope of type I and II collagens; 234CEQ=collagenase-generated cleavage neoepitope of type II collagen. Note: the Y-axes
(biomarker concentrations) for the graphs of PICP (C) and CPII (D), and the Y-axes for the graphs of COL2-3/4Cshort (G) and 234CEQ (H)
have been similarly scaled to illustrate the relative predominance of the type I collagen products (PICP and COL2-3/4Cshort) over the type
II collagen products (CPII and 234CEQ) in the sera of these foals during the first year of life.
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CPII levels in synovial fluids from osteochondrotic joints of
young horses compared to levels in fluids from normal
joints36.
As with CTx1, there are few published reports on the
effects of exercise on body fluid levels of CPII. There was
no effect of exercise on the synovial fluid levels of this
propeptide in human athletes, even though they had lower
levels than nonathletes58. Studies in dogs have reported
exercise-induced changes in the collagen of articular carti-
lage, but little in terms of type II collagen content or
cross-links59,60. It has previously been noted that there was
no exercise effect on the collagen component of articular
cartilage specimens from the metacarpophalangeal joints
of the 24 foals in the current study sampled at 5 months of
age22. Our biomarker analyses suggest that forced exer-
cise in horses during early life may result in a significant
decrease in type II collagen synthesis compared to either
pasture exercise or stall rest.
The significant differences between the exercise groups
for the changes from baseline in the serum levels of CTx1
and CPII essentially disappeared at 5 months of age. This
is consistent with adaptive responses to the forces being
applied by the different exercise regimens within the devel-
oping skeletal system of these foals. That the significant
exercise-induced differences in the serum levels of CPII
and CTx1 disappeared completely with an additional
6 months of free exercise, further supports the positive
effects of normal exercise on collagen metabolism in foals.
Significant exercise-induced changes in proteoglycan
content and synthetic capacity of articular cartilage
removed from various joints of these foals have previously
been reported22,31. However, we found no significant differ-
ences between the groups in terms of the biomarkers that
represent aggrecan turnover (sGAG and CS-846). This
suggests that the evaluation of these byproducts of proteo-
glycan turnover in serum may not represent what is
happening at the tissue level, perhaps due to rapid
processing and dilution of these metabolites upon clear-
ance from the affected joints to the systemic circulation.
This is supported by a study involving horses in which there
was an increase in the serum levels of the sGAG, keratan
sulfate, immediately after training, but a return to
pre-training concentrations within 1 h after exercise24.
We confirm the previously described age-related
decreases in the serum levels of certain biomarkers of
skeletal metabolism in horses34,61. We identified however,
a significant increase in the serum levels of CPII up to
7 months, and CTx1 up to 9 months of age. This is the first
known report of increasing levels of skeletal biomarkers in
the body fluids of young horses during the first year of life.
The finding for CTx1 may reflect increasing isomerization
and maturity of bone collagen degradation fragments
detected by the assay with increasing foal age.
It is important to note that our population of foals was
genetically predisposed to develop osteochondrosis and all
foals examined at 5 months had osteochondrotic lesions25.
Thus, there is the potential for this inherent abnormality to
confound the effects of exercise on the serum levels of
biomarkers of skeletal tissue metabolism. However, it was
reported that the exercise regimen used in this study for the
first 5 months did not significantly affect the number
or severity of osteochondrotic lesions in these foals25.
Nevertheless, our results need to be confirmed in a larger
population of foals, free of any predisposition for, or the
presence of orthopedic disease.
We have shown the potential for monitoring the effects of
exercise on the skeletal system in the developing animal
during the dynamic first postpartum months, by evaluating
the serum levels of specific metabolic biomarkers. By
measuring the serum levels of biomarkers of cartilage
collagen synthesis (CPII) and bone collagen degradation
(CTx1), we were able to distinguish the exercise groups
and suggest that the pastured foals had greater type II
collagen synthesis and less type I collagen degradation
than the stall-rested or trained foals. Our findings, based on
the serum biomarker analyses, support those from the
previously reported tissue biochemical analyses in these
foals62, in that pasture exercise was the best of the options
employed in this study for the development of a healthy
musculoskeletal system. Routine sampling and assay-
ing for these biomarkers may allow the identification and
monitoring of potentially adverse effects of exercise on
skeletal development in animals and humans.
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